ERK3 Promotes Endothelial Cell Functions by Upregulating SRC-3/SP1-Mediated VEGFR2 Expression

Role of the Nuclear Receptor Coactivator AIB1/SRC-3 in Angiogenesis and Wound Healing

(2012) Maram Al-Otaiby et al.   AMERICAN JOURNAL OF PATHOLOGY

Steroid receptor coactivator-3 as a potential molecular target for cancer therapy

(2012) Jean Ching-Yi Tien et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

ERK3 signals through SRC-3 coactivator to promote human lung cancer cell invasion

(2012) Weiwen Long et al.   JOURNAL OF CLINICAL INVESTIGATION

Activation and Function of the MAPKs and Their Substrates, the MAPK-Activated Protein Kinases

(2011) M. Cargnello et al.   MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS

A Novel Function of p38-Regulated/Activated Kinase in Endothelial Cell Migration and Tumor Angiogenesis

(2011) N. Yoshizuka et al.   MOLECULAR AND CELLULAR BIOLOGY

A functional link between the human cell cycle-regulatory phosphatase Cdc14A and the atypical mitogen-activated kinase Erk3

(2010) Christina Aaen Hansen et al.   CELL CYCLE

SRC-3Δ4 Mediates the Interaction of EGFR with FAK to Promote Cell Migration

(2010) Weiwen Long et al.   MOLECULAR CELL

Inducible gene targeting in the neonatal vasculature and analysis of retinal angiogenesis in mice

(2010) Mara E Pitulescu et al.   Nature Protocols

VEGFs and receptors involved in angiogenesis versus lymphangiogenesis

(2009) Marja Lohela et al.   CURRENT OPINION IN CELL BIOLOGY

Loss of Erk3 function in mice leads to intrauterine growth restriction, pulmonary immaturity, and neonatal lethality

(2009) S. Klinger et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

TNF primes endothelial cells for angiogenic sprouting by inducing a tip cell phenotype

(2008) R. C. A. Sainson et al.   BLOOD

The Nuclear Receptor Coactivator Amplified in Breast Cancer-1 Is Required for Neu (ErbB2/HER2) Activation, Signaling, and Mammary Tumorigenesis in Mice

(2008) M. P. Fereshteh et al.   CANCER RESEARCH

Activation loop phosphorylation of the atypical MAP kinases ERK3 and ERK4 is required for binding, activation and cytoplasmic relocalization of MK5

(2008) Paul Déléris et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Microtubule-Targeted Drugs Inhibit VEGF Receptor-2 Expression by both Transcriptional and Post-Transcriptional Mechanisms

(2008) Markus Meissner et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY